Palatin Technologies, Inc. (PTN)
13.08
+0.24
(+1.87%)
USD |
NASDAQ |
Sep 03, 16:00
13.08
0.00 (0.00%)
Pre-Market: 08:29
Palatin Technologies Cash from Investing (Quarterly) : -0.0385M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0385M |
| December 31, 2025 | -0.0128M |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.63M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 2.50M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | -0.0049M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 9.462M |
| September 30, 2023 | 2.993M |
| June 30, 2023 | -3.045M |
| March 31, 2023 | -0.1169M |
| December 31, 2022 | -0.1234M |
| September 30, 2022 | -0.1412M |
| June 30, 2022 | -0.0371M |
| March 31, 2022 | -0.0774M |
| December 31, 2021 | -0.0891M |
| September 30, 2021 | -0.0578M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.0057M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0629M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -0.0361M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.013M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.25M |
| September 30, 2017 | -0.0095M |
| June 30, 2017 | 0.5416M |
| March 31, 2017 | 0.45M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -1.387M |
| September 30, 2015 | -0.0177M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 1.500M |
| December 31, 2013 | 2.25M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | -0.0424M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.417M |
| Cash from Financing (Quarterly) | 0.1389M |
| Free Cash Flow | -14.98M |
| Free Cash Flow Per Share (Quarterly) | -1.139 |
| Free Cash Flow to Equity (Quarterly) | -4.394M |
| Free Cash Flow to Firm (Quarterly) | -4.454M |
| Free Cash Flow Yield | -54.04% |